Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neuroblastoma that involves the retroperitoneal space.
Biomarker and diagnostic research for retroperitoneal neuroblastoma has been reported in the published literature.
No clinical trials have been registered for retroperitoneal neuroblastoma.
11 publications have been identified in PubMed for retroperitoneal neuroblastoma. Research spans Case Report / Case Series (55%), Epidemiology / Natural History (18%), and Diagnostic / Biomarker (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 55% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 11:55 AM UTC
Disease patterns and progression
2 |
18% |
Testing and diagnosis research | 1 | 9% |
Research summaries | 1 | 9% |
Laboratory research | 1 | 9% |
He X (2026). [PMID: 42239484](https://pubmed.ncbi.nlm.nih.gov/42239484/). *Front Pediatr*. [Epidemiology / Natural History]
Karna NK (2026). [PMID: 41913258](https://pubmed.ncbi.nlm.nih.gov/41913258/). *Journal of medical case reports*. [Case Report / Case Series]
Li Y (2025). [PMID: 40775759](https://pubmed.ncbi.nlm.nih.gov/40775759/). *BMC cancer*. [Diagnostic / Biomarker]
Fan QX (2025). [PMID: 41607458](https://pubmed.ncbi.nlm.nih.gov/41607458/). *Frontiers in endocrinology*. [Case Report / Case Series]
Adorisio R (2025). [PMID: 40681266](https://pubmed.ncbi.nlm.nih.gov/40681266/). *JACC. Case reports*. [Case Report / Case Series]
Srivatsa S (2025). [PMID: 39809037](https://pubmed.ncbi.nlm.nih.gov/39809037/). *The Journal of surgical research*. [Epidemiology / Natural History]
Cernaianu G (2024). [PMID: 39080686](https://pubmed.ncbi.nlm.nih.gov/39080686/). *BMC surgery*. [Basic Science / Preclinical]
Wang L (2024). [PMID: 38714401](https://pubmed.ncbi.nlm.nih.gov/38714401/). *Asian journal of surgery*. [Review / Meta-Analysis]
Kamboj M (2024). [PMID: 39412939](https://pubmed.ncbi.nlm.nih.gov/39412939/). *Journal of cancer research and therapeutics*. [Case Report / Case Series]
Rendón Mejía NA (2024). [PMID: 38846926](https://pubmed.ncbi.nlm.nih.gov/38846926/). *Urology case reports*. [Case Report / Case Series]
AI-curated news mentioning retroperitoneal neuroblastoma
Updated Sep 15, 2026
A new in vivo cascade cyclic amplification strategy has been developed to detect MYCN mRNA expression levels in neuroblastoma. This innovative approach could enhance the understanding of MYCN's role in the disease.
Researchers developed CoCoRV-nf, a cost-effective tool for analyzing rare variants using external biobank data. This tool has identified new candidate predisposition genes for amyotrophic lateral sclerosis and neuroblastoma.
A weighted patient-level analysis of three clinical studies reveals a significant association between dinutuximab beta exposure and post-end-of-treatment survival in neuroblastoma patients. This research underscores the potential impact of treatment levels on long-term outcomes.